Purple Biotech (PPBT) Current Leases (2019 - 2026)

Purple Biotech (PPBT) has reported Current Leases for 8 consecutive years, with $184000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Current Leases rose 34.31% year-over-year to $184000.0 in Q1 2026; TTM through Mar 2026 was $184000.0, a 34.31% increase from a year earlier, with the FY2025 full-year figure at $244000.0, up 33.33% from the prior year.
• Current Leases was $184000.0 for Q1 2026 at Purple Biotech, down from $244000.0 in the prior quarter.
• Over five years, Current Leases peaked at $244000.0 in Q4 2025 and troughed at $103000.0 in Q2 2025.
• A 5-year average of $184117.6 and a median of $186000.0 in 2024 frame the typical range for Current Leases.
• Across the five-year window, Current Leases plunged 43.41% in 2025 and surged 34.31% in 2026, its largest moves.
• Over 5 years, Current Leases stood at $194000.0 in 2022, then declined by 3.09% to $188000.0 in 2023, then retreated by 2.66% to $183000.0 in 2024, then surged by 33.33% to $244000.0 in 2025, then slipped by 24.59% to $184000.0 in 2026.
• The last three Current Leases figures came in at $184000.0 (Q1 2026), $244000.0 (Q4 2025), and $207000.0 (Q3 2025), per Business Quant data.